New book by Larry Connors Click here Improve your trading - See how
Dr. Bedi's R&K Bedi Limited will handle Oragenics products throughout key Middle East including Saudi Arabia, Egypt, Jordan, Kuwait, Bahrain, Lebanon, Oman, Qatar, United Arab Emirates, Yemen and Israel as well as Near East countries including Armenia, Azerbaijan, Georgia, Turkmenistan and Turkey, the Company noted in a release.
Based at King's College London, Dr. Bedi served as the UK's Chief Dental Officer from 2002 to 2005 and in 2009 helped form the Global Child Dental Health Taskforce, established to support governments impact on improving children's oral health. Currently operating in 11 countries, the Taskforce works with national oral care programs reaching 500 million children and parents. He also holds an honorary chair at University College London where he was the co-director of the World Health Organization Collaborating Centre at the Eastman Dental Institute (1998-2008) and an honorary "Extraordinary Professorship" in Paediatric Dentistry at the University of the Western Cape, South Africa (2007-2010).
Dr. Bedi is a Past President of the British Society for Disability and Oral Health (2002), President of the Education Research Group of the International Association for Dental Research (IADR) (2002-2004) and chair of the IADR Regional Development Programme Committee (2002-2004). He has published over 170 scientific papers and 4 books and examined and lectured in over 40 countries.
As Chief Dental Officer, Dr. Bedi led a team which spearheaded the passage of three major pieces of legislation; Health and Social Care Act (dental clauses) 2004, Water Act (Fluoridation) 2004 and the Section 60 (2005) order reforming the General Dental Council. For 3 years he led the reform of NHS primary dental care and was the Department of Health sponsor for the Dental Practice Board and Dental Vocational Training Authority. He chaired the UK European Union Presidency dental programme, September 2005. In 2003 he was given the national Asian Guild award and in 2004 the Asian Jewel award. In 2005 he featured on the front cover of the Asian Power 100 and was awarded the annual national British Association for Physicians of Indian Origin award. In 2005 he was given the USA Public Health Service medal.
As exclusive Middle East and Near East representative for Oragenics, Dr. Bedi will introduce the company's core products to both the government and private sectors within each country. In the government area, Dr. Bedi will work to integrate the Oragenics line into each country's official oral care programs. For the private sector, he will work with local distributors and wholesalers to launch Oragenics products into such markets as dental practices, pharmacies and mass retailers.
"We are extremely pleased to forge this important alliance with Dr. Raman Bedi, a globally-respected figure in oral care whose extensive work through the years has impacted the lives of millions around the world. Dr. Bedi is a renowned dental authority across the Middle East, and his exclusive representation of our product line will play a significant role as we launch within this significant international market," said Gerry David, Executive Vice President of Sales and Marketing for Oragenics, Inc.
((Comments on this story may be sent to health@closeupmedia.com))
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.
It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.
HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.
The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302
© Copyright 2009 The Connors Group, Inc.
